Association of the t(12;22)(q13;q12) EWS/ATF1 rearrangement with polyphenotypic round cell sarcoma of bone: a case report

Am J Surg Pathol. 2005 Dec;29(12):1673-9. doi: 10.1097/01.pas.0000176434.19197.c1.

Abstract

The t(12;22)(q13;q12) chromosomal rearrangement results in an EWS/ATF1 fusion transcript and is associated with clear cell sarcoma (CCS). CCS is an uncommon tumor arising in tendons and aponeuroses of the extremities and shows evidence of melanocytic differentiation at the light microscopic, immunohistochemical, and/or ultrastructural level. Only 5 cases have been reported to arise in bone, none of which had molecular confirmation of the diagnosis. The current report describes a 7-year-old girl with a primary round cell sarcoma of the left humerus showing polyphenotypic differentiation on immunohistochemical analysis. Antibodies directed at melanocytic antigens were negative, and there was no evidence of melanocytic differentiation by light microscopy or ultrastructural analysis. Cytogenetic analysis revealed rearrangement of the EWS locus within 22q12. RT-PCR and sequence analysis revealed the presence of a fusion transcript bringing together exon 7 of EWS with exon 5 of ATF1, consistent with a type 2 transcript reported in association with CCS. However, given the lack of morphologic features usually present in CCS, a diagnosis of polyphenotypic round cell sarcoma was made. This tumor thus expands the spectrum of neoplasms associated with the t(12;22)(q13;q12) rearrangement.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Base Sequence
  • Biopsy
  • Child
  • Chromosomes, Human, Pair 12*
  • Chromosomes, Human, Pair 22*
  • Cytogenetic Analysis
  • DNA, Neoplasm / analysis
  • Disease-Free Survival
  • Exons
  • Female
  • Follow-Up Studies
  • Humans
  • Humerus / diagnostic imaging
  • Humerus / pathology
  • Humerus / surgery
  • Immunohistochemistry
  • Lymph Node Excision
  • Magnetic Resonance Imaging
  • Molecular Sequence Data
  • Neoplasm Staging
  • Oncogene Proteins, Fusion / chemistry
  • Oncogene Proteins, Fusion / genetics*
  • Radiography
  • Radionuclide Imaging
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sarcoma, Clear Cell / diagnosis
  • Sarcoma, Clear Cell / diagnostic imaging
  • Sarcoma, Clear Cell / drug therapy
  • Sarcoma, Clear Cell / genetics*
  • Sarcoma, Clear Cell / pathology*
  • Sarcoma, Clear Cell / surgery
  • Sarcoma, Clear Cell / ultrastructure
  • Sequence Analysis, DNA
  • Time Factors
  • Translocation, Genetic*
  • Treatment Outcome

Substances

  • DNA, Neoplasm
  • Oncogene Proteins, Fusion